Drug intelligence / Profile preview

micafungin

Development stage
Approved
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Intravenous
01

Overview

Micafungin is a semisynthetic lipopeptide antifungal agent of the echinocandin class. It is used for the treatment and prevention of various Candida infections, including candidemia (fungal infection in the blood), acute disseminated candidiasis, esophageal candidiasis (infection of the throat), candida peritonitis and abscesses (infection in the abdomen), and as prophylaxis against Candida infections in patients undergoing hematopoietic stem cell transplantation. Micafungin acts by inhibiting beta‑1,3‑D‑glucan synthase—an enzyme essential for fungal cell wall synthesis—leading to disruption of fungal cell wall integrity and ultimately fungal death. It is fungicidal against some Candida species but generally fungistatic against Aspergillus species[1][2][7].

Brand names
Mycamine
Other names
micafunginemicafunginumMicafunginaPneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl]-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)
02

Targets

GLS1 (Glutaminase 1)

Beyond the preview

Go deeper on micafungin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on micafungin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call